The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Source: [MarketWatch](https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c?mod=mw_rss_topstories)
In the coming years, increasingly larger and more powerful quantum systems are expected to tackle problems that are difficult or impossible to solve using conventional computers. However, the more powerful quantum simulations become, the more difficult it is to independently verify their results...
Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced the recurrence of melanoma, the deadliest form of skin cancer. Madison Muller reports on "Bloomberg Open Interest.
2 points, 0 comments on Hacker News
6 points, 0 comments on Hacker News
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.